The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2019 | Managing patients that have undergone CAR T-cell therapy
Yi Lin
• 26 Mar 2019
Yi Lin, MD, PhD, MSc, from Mayo Clinic, Rochester, MN, speaks about the management of patients undergoing CAR T-cell therapy. Dr Lin was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.
